Results
1
Stocks where the price continues to rise after more than a year of consistent gains.
1 companies
Sareum Holdings
Market Cap: UK£36.7m
A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.
SAR
UK£0.28
7D
21.7%
1Y